saccharomyces boulardii

General

Complementary/Alternative Medicine: This monograph describes a natural or herbal product that is not subject to FDA guidelines for medicines. Patients and clinicians are advised to read package labels carefully to ensure safe and efficacious use.

Pronunciation:
sak-a-roe-mye-seez boo-lar-dee


Trade Name(s)

  • Brewer's yeast
  • probiotics

Ther. Class.
antidiarrheals
anti irritable bowel syndrome agents

Common Uses

  • Treatment and prevention of diarrhea
  • Irritable bowel syndrome.

Action

Saccharomyces boulardii is a non-pathogenic yeast used to colonize the gastrointestinal tract.

Therapeutic Effect(s):

Reduced number of bowel movements.

Pharmacokinetics

Absorption: Unknown

Distribution: Unknown

Metabolism and Excretion: Unknown

Half-life: Unknown

TIME/ACTION PROFILE

ONSETPEAKDURATION
POunknown3 daysunknown

Contraindication/Precautions

Contraindicated in:

  • Hypersensitivity to yeast.

Use Cautiously in:

  • Pregnancy and lactation;
  • Immunocompromised patients (↑ risk of fungemia)

Adverse Reactions/Side Effects

GI: bloating, constipation, flatulence

Misc: fungemia, ↑ thirst

* CAPITALS indicate life-threatening.
Underline indicate most frequent.

Interactions

Natural Drug Interaction

Antifungalsmay decrease effectiveness of Saccharomyces boulardii

Natural-Natural:

None.

Route/Dosage

PO: (Adults) 250–500 mg two to four times a day.

Availability

Capsules: 250 mg

Assessment

  • Assess patient for abdominal distention, presence of bowel sounds, and usual pattern of bowel function.
  • Assess color, consistency, and amount of stool produced.

Lab Test Considerations:

Monitor CBC periodically during therapy.

Potential Diagnoses

  • Diarrhea (Indications)

Implementation

  • PO: Administer as directed.

Patient/Family Teaching

  • Instruct patient to take as directed.
  • Advise female patient to notify health care professional if pregnancy is planned or suspected or if breastfeeding.

Evaluation/Desired Outcomes

Resolution of diarrhea and decrease in number of loose stools.

saccharomyces boulardii is a sample topic from the Davis's Drug Guide.

To view other topics, please or purchase a subscription.

Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Learn more.

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - saccharomyces boulardii ID - 109984 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109984/all/saccharomyces_boulardii PB - F.A. Davis Company ET - 16 DB - Nursing Central DP - Unbound Medicine ER -